External News
New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Read more ➡News
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
Read MorePress Release
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Read MorePress Release
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Read MorePress Release
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
Read MoreExternal News
Benaroya Research Institute awarded $5.8M from NIH for immunology-related COVID research
Read more ➡Press Release
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
Read MoreNews
Dr. Harrison Awarded First NOSTER Science Microbiome Prize
Read MoreExternal News
Benaroya Research Institute at Virginia Mason is a leader in finding cure to autoimmune diseases
Watch video ➡External News
Gene-edited T cells to treat diabetes inch closer to clinical trials
Read more ➡External News
Engineered T cells for type 1 diabetes move closer to clinic
Read more ➡External News
Are those ‘Covid toes,’ or should you be wearing slippers?
Read more ➡External News
Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01
Read more ➡External News
Healing the Immune System: Autoimmune Breakthroughs Offer New Hope
Learn more ➡External News